1 / 21

Finance Team National Hispanic Medical Association Leadership Fellowship 2003

Finance Team National Hispanic Medical Association Leadership Fellowship 2003. Jose Castro MD Elsa Escalera MD Inginia Genao MD Advisor: Charles Brecher PhD. The New Medicare Law: Implications for vulnerable population. Outline.

garson
Télécharger la présentation

Finance Team National Hispanic Medical Association Leadership Fellowship 2003

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript


  1. Finance TeamNational Hispanic Medical AssociationLeadership Fellowship 2003 Jose Castro MD Elsa Escalera MD Inginia Genao MD Advisor: Charles Brecher PhD

  2. The New Medicare Law:Implications for vulnerable population

  3. Outline • Overview Medicare prescription drug improvement and modernization act of 2003 • Impact on the dual eligibles (Medicaid and Medicare) • Recommendations • Summary

  4. Overview of the Medicare prescription drug improvement and modernization act of 2003. • 41.7 million beneficiaries of Medicare to new coverage of prescription drugs • $ 410 billion (calculated by CBO) 2004-2013 • Voluntary benefit effective January 1, 2006 • Annual premium in 2006 about $420—can vary by plan • Annual $250 deductible indexed to drug spending • Coverage gap (“donut hole”)—no coverage for spending between $2,250 and $5,100 • Subsidies for low-income beneficiaries

  5. Standard Drug Benefit

  6. Dual Eligibles

  7. Sources of Supplemental CoverageAmong Non-InstitutionalizedMedicare Beneficiaries, 2000 * Includes Medicaid, Veteran Affairs, and various other programs. Source: Analysis of 2000 MCBS by Bruce Stuart for The Commonwealth Fund.

  8. Dual eligibles: Who Are They? • Medicaid fill gaps in Medicare > 7 million low-income seniors: enrolled in both Medicaid/Medicare. • Must have income well bellow the poverty line and minimal assets to qualify for Medicaid, • Dual eligibles are much poorer than other Medicare beneficiaries. • They also tend to have far more extensive health care needs than other Medicare beneficiaries:

  9. Dual Eligibles: How poor, how sick? • 70% of dual eligibles have annual incomes < $ 10 K compared to 13 % of all other Medicare beneficiaries. • More than twice as likely to be in fair or poor health as other Medicare beneficiaries (52% versus 24%). • ~ 25% of dual eligibles are in long-term care facilities compared to 2% of other Medicare beneficiaries. • Dual eligibles are more than twice as likely to have Alzheimer’s (6% versus 3%), more likely to have diabetes (24% versus 17%) and to have suffered a stroke (14% versus 11%) than other Medicare beneficiaries.

  10. New Medicare Law for Dual eligibles • No deductible and no premium for enrolling in an average or low cost plan. • Special assistance with cost-sharing obligations (no doughnut hole for dual eligibles). Will not pay for 100% once they exceed limit of $2,250. • Oincome up to 100% of poverty: no more than $1/generic and $ 3/brand name drug in 2006. Majority will fall into this category. • O       dual eligibles with income >100% of poverty. $2/generic and $5/brand name drug in 2006.

  11. Impacts on Dual Eligibles: Should the Fight Continue? • Complex choices • Navigating the system • Variations from state to state • Drug coverage restrictions under part D plan • Array of drugs covered • Cost-sharing

  12. III Recommendations • Focus in Hispanics: will have additional challenges. • Measuring outcomes.

  13. In 2002, almost 2 million Hispanics > 65 ys. • Data gathering should be focused on this group to estimate the impact the new Medicare law. • Data should be the best advocacy tool. • One way to obtain reliable data is research.

  14. Outcomes research • Outcome research: measures outcomes. • Set of analytic methods that produce information about the benefits, risks, and costs of health care services.

  15. Measuring outcomes • There are many potential measurements that can be incorporated in the study, but should be oriented to the particular characteristics of the study population, for example: • Measure Example • Mortality cardiovascular associated mortality • Physiology blood pressure • Clinical events stroke • Functional status SF-36, a 36 item health survey • Experience with care Consumer Assessment of Health Plan

  16. Summary • Good benefits for many beneficiaries. • May be a challenge for the most vulnerable, in particular Hispanics. • Outcome research focus in this population and plan in advance.

  17. Senate Majority Leader Bill Frist said, “This bill is an extraordinary day for seniors and indeed all Americans…The legislation we just passed is epochal…It modernizes Medicare to provide 21st century care for our seniors.”

  18. Senate Minority Leader Tom Daschle predicts that seniors would mobilize as they did 38 years ago for the original Medicare Bill once they learn how the bill works. “They [lobbyists] will do well. Our seniors will not, and that is why the fight will go on.”

More Related